Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Peginterferon Alfa-2a (Pegasys®)

Brand: Pegasys®
NICE TA: 300
Indication: Hepatitis C (children and young people) (NICE TA300)
Disease category: Malignant Disease & Immunosuppression
Commissioning responsibility: NHS England
PbR excluded: Yes


Peginterferon alfa in combination with ribavirin is recommended, within its marketing authorisation, as an option for treating chronic hepatitis C in children and young people either as 24 week or 48 week course. This updates section 1.7, bullet 2 of TA75 and section 1.6 of TA106.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG